CEACAM5 and cancer: In multivariate analysis, age, high r-CEA level, initial lymphovascular invasion, advanced T and N stage, poor histology, presence of perineural invasion and tumor budding, disease-free interval less than 12 months, and conservative treatment after recurrence were associated with poorer cancer-specific survival (Table 2).